Cargando…
Non-cellular immunotherapies in pediatric central nervous system tumors
Central nervous system (CNS) tumors are the second most common type of cancer and the most common cause of cancer death in pediatric patients. New therapies are desperately needed for some of the most malignant of all cancers. Immunotherapy has emerged in the past two decades as an additional avenue...
Autor principal: | Rumler, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598668/ https://www.ncbi.nlm.nih.gov/pubmed/37885882 http://dx.doi.org/10.3389/fimmu.2023.1242911 |
Ejemplares similares
-
The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors
por: Le, Thanh-Phuong, et al.
Publicado: (2017) -
Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs
por: Li, Yongsheng, et al.
Publicado: (2022) -
A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System Malignancies
por: Rozowsky, Jacob S., et al.
Publicado: (2022) -
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors
por: Del Baldo, Giada, et al.
Publicado: (2023) -
Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors
por: Upreti, Deepak, et al.
Publicado: (2020)